Lentiviral gene therapy for X-linked chronic granulomatous disease
Monday, January 27, 2020
Published in Nature Medicine

At left, image shows white blood cells (red) from one of the X-CGD clinical trial participants before gene therapy. At right, after gene therapy, white blood cells from the same patient show the presence of the chemicals (blue) needed to attack and destroy bacteria and fungus.